Real-World Outcomes With Sacituzumab Govitecan Match ASCENT in Single-Center Study
March 5th 2023In a single-center study, investigators assessed real-world outcomes in patients with metastatic metastatic triple-negative breast cancer treated with the antibody-drug conjugate sacituzumab govitecan-hziy.
Miami Breast Keynotes Highlight the Call to Action for Advocacy Efforts in Breast Cancer
March 4th 2023Lindsay Avner Kaplan and Nancy G. Brinker, the keynote speakers of the 40th Annual Miami Breast Cancer Conference, discuss the need to confront social determinants of health for patients and drive the public conversation and interpretation of personal and clinical stories in health care.